Latest stories on NVS
Novartis price target raised to CHF 130 from CHF 120 at RBC Capital
The Fly63 · neutralanalyst
Monte Rosa Therapeutics collaborator Novartis initiates MGD MRT-6160 study
The Fly63 · neutralproduct/pr
Novartis price target raised to CHF 130 from CHF 116 at UBS
The Fly63 · neutralanalyst
Novartis price target raised to $163 from $156 at Morgan Stanley
The Fly63 · neutralanalyst
Novartis' 'Critically' Important Update Ahead Of November
Investors.com58 · neutralgeneral
Q3 2026 Novartis AG Earnings Call Transcript
GuruFocus50 · neutralearnings
Novartis earnings analysis: questions answered and next catalysts
Investing.com Markets55 · neutralearnings
Novartis (NVS) Q3 2026 Earnings Call Transcript
The Motley Fool64 · neutralearnings
Novartis (NVS) Raises 2026 Profit Outlook Amid AI Cost Savings
GuruFocus67 · bullishearnings
Novartis Raises Guidance Despite Drug-Trial Setbacks Hitting Profit — 2nd Update
Morningstar64 · neutralearnings
Novartis takes $1.9bn writedown on key drug after blockbuster Avidity acquisition
Financial Times42 · neutralearnings
Novartis Stops Late-Stage Trial for Key Drug in Rare Neuromuscular Disease
MarketWatch22 · bearishproduct/pr
European Stocks Rebound
Trading Economics58 · neutralgeneral
Health Care Roundup: Market Talk
WSJ Markets50 · neutralgeneral
Novartis raised profit outlook in Q3 2026 earnings despite charge
Quartz64 · neutralearnings
Novartis Raises 2026 Profit Forecast After Q3 Sales Rise 4% to $14.52 Billion
InvestorsHub67 · bullishearnings
Novartis lifts profit outlook as new medicines counter generic erosion
Seeking Alpha67 · bullishearnings
Novartis reaffirms FY26 net sales growth view up low single-digit
The Fly56 · neutralearnings
Novartis reports Q3 core EPS $2.46 vs. $2.25 last year
The Fly64 · neutralearnings
Novartis Raises Guidance Despite Drug-Trial Setbacks Hitting Profit — Update
Morningstar64 · neutralearnings
Novartis (NVS) Shares Rise 3.1% on Upgraded Core Operating Income Outlook
GuruFocus64 · neutralearnings
Novartis CEO says AI has tangibly improved P&L for the first time
CNBC63 · neutralproduct/pr
Dow Jones Top Company Headlines at 3 AM ET: Novartis Raises Guidance Despite Trial Setbacks Hitting Profit | HSBC ...
Morningstar58 · neutralearnings